Last reviewed · How we verify

NCT07054723: GOCE

Surviving Daily Life

Recruiting now Last updated 22 October 2025
What this trial tests

trial testing Mobile Daily Diary in Stress in 30 participants. Currently enrolling.

Timeline
2 October 2025
Primary endpoint
31 October 2026
31 October 2026

Quick facts

Lead sponsorThomas Jefferson University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment30
Start date2 October 2025
Primary completion31 October 2026
Estimated completion31 October 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Thomas Jefferson University

Who can join

40 and older, female only, with Stress or Cognitive Change. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary goal of this project is to evaluate the feasibility of a 14-day mobile daily diary study among racially diverse breast cancer survivors. Further, the investigators will examine the validity and reliability of the daily stress and daily cognitive performance measures among breast cancer survivors. This pilot project will recruit 30 racially diverse breast cancer survivors (Asian, Black, Latina, and white; ages 40 and older; at least five years post-diagnosis) who are patients at the Sidney Kimmel Comprehensive Cancer Center. The daily diary survey questions will be available in English, Spanish, and Chinese to accommodate the preferred language of the target participants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stress

Currently open trials in the same condition.

Other Thomas Jefferson University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07054723.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing